MANNKIND CORPORATION
Last · —$3.02-0.03 (-0.98%)live · yahoo · 1h ago
Market cap$971.06M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $199.5M |
|---|---|
| Operating income | $-2.0M |
| Net income | $-35.7M |
| Free cash flow | $-30.7M |
| Operating margin | -1.0% |
| Net margin | -17.9% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.00
Est. revenue
110.3M
Press & signals
- GlobeNewswire
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
- GlobeNewswire
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
- GlobeNewswire
MannKind Announces $50 Million Private Placement